| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 355-360, Copyright © 1994 by Endocrine Society
ARTICLES |
PF Watson, AP Pickerill, R Davies and AP Weetman
Department of Medicine, University of Sheffield Clinical Sciences Center, Northern General Hospital, United Kingdom.
Cytokines have a central role in the generation of an autoimmune response and can directly affect the target organ. In Graves' disease, both the infiltrating mononuclear cells and the thyroid follicular cells produce certain cytokines, but the relative contribution of each is unclear, and there are conflicting data on the exact profile of cytokines expressed within the thyroid. To clarify these issues, we used the method of reverse transcription-polymerase chain reaction amplification to analyze cytokine gene expression by intrathyroidal lymphocytes (ITL) and purified thyroid follicular cells (TFC) from six patients with Graves' disease. All ITL samples were positive for interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF alpha) messenger ribonucleic acids (mRNAs). Four samples were positive for IL-2 mRNA, and of these, three were also positive for interferon-gamma (IFN gamma). All TFC samples contained IL-6 and IL-8 mRNAs, even after depletion of CD3-positive T- cells. One TFC sample was additionally positive for IL-10 and TNF alpha mRNAs, and in the case of IL-10, this signal was not eliminated by CD3- positive T-cell depletion. IL-4 was not detected in any sample of ITL, TFC, or whole tissue. Semiquantitative analysis showed that the ITL fraction represented the major source of IL-6, IL-8, and TNF alpha mRNAs. By contrast, only three of five multinodular goiter samples were positive for IL-1 alpha mRNA; of these, two were also positive for IL- 6, and 1 was positive for IL-8 mRNA. One multinodular goiter sample was positive for IL-8 mRNA alone, but IL-2, IL-4, IL-10, and TNF alpha mRNAS were not detected. These results suggest that although the TFC themselves may express certain cytokines, the ITL population represents the most important source of cytokine production in Graves' thyroid glands. The presence of IL-2, IFN-gamma, and TNF alpha and the absence of IL-4 mRNA in samples of ITL indicate a pattern of cytokine production that most closely resembles that of the TH1 helper T-cell subset. Given the etiological role of thyroid-stimulating antibodies in Graves' disease, the production of which is likely to depend upon TH2 helper T-cell function, it is perhaps surprising that the TH1 subset appears to predominate. It is possible that IL-10 is important in stimulating intrathyroidal autoantibody production, and this cytokine may also play a role in inhibiting cell-mediated thyroid injury in Graves' disease.
This article has been cited by other articles:
![]() |
A. Antonelli, M. Rotondi, S. M. Ferrari, P. Fallahi, P. Romagnani, S. S. Franceschini, M. Serio, and E. Ferrannini Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Involvement in Graves' Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazziotti, F. Sorvillo, M. Piscopo, F. Morisco, M. Cioffi, G. Stornaiuolo, G. B. Gaeta, A. M. Molinari, J. H. Lazarus, G. Amato, et al. Innate and Acquired Immune System in Patients Developing Interferon-{alpha}-Related Autoimmune Thyroiditis: A Prospective Study J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4138 - 4144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S. M. Ferrari, A. Paolicchi, E. Ferrannini, and M. Serio Increase of interferon-{gamma} inducible {alpha} chemokine CXCL10 but not {beta} chemokine CCL2 serum levels in chronic autoimmune thyroiditis Eur. J. Endocrinol., February 1, 2005; 152(2): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Chan, C. C. Chow, and C. S. Cockram Interferon alpha treatment and endocrine disease J R Soc Med, October 1, 2003; 96(10): 481 - 485. [Full Text] [PDF] |
||||
![]() |
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression Endocrinology, July 1, 2003; 144(7): 2856 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
E H Kemp, R A Metcalfe, P F Watson, and A P Weetman HLA-G does not have a pathophysiological role in Graves' disease J. Clin. Pathol., June 1, 2003; 56(6): 475 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, and Y. Inoue Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1194 - 1199. [Abstract] [Full Text] |
||||
![]() |
F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867. [Abstract] [Full Text] |
||||
![]() |
T. Arao, I. Morimoto, A. Kakinuma, O. Ishida, K. Zeki, Y. Tanaka, N. Ishikawa, K. Ito, K. Ito, and S. Eto Thyrocyte Proliferation by Cellular Adhesion to Infiltrating Lymphocytes through the Intercellular Adhesion Molecule-1/Lymphocyte Function-Associated Antigen-1 Pathway in Graves' Disease J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 382 - 389. [Abstract] [Full Text] |
||||
![]() |
B. M. Jones, C. C. H. Kwok, and A. W. C. Kung Effect of Radioactive Iodine Therapy on Cytokine Production in Graves' Disease: Transient Increases in Interleukin-4 (IL-4), IL-6, IL-10, and Tumor Necrosis Factor-{alpha}, with Longer Term Increases in Interferon-{gamma} Production J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4106 - 4110. [Abstract] [Full Text] |
||||
![]() |
Y. Ashhab, O. Dominguez, M. Sospedra, C. Roura-Mir, A. Lucas-Martín, and R. Pujol-Borrell A One-Tube Polymerase Chain Reaction Protocol Demonstrates CC Chemokine Overexpression in Graves' Disease Glands J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2873 - 2882. [Abstract] [Full Text] |
||||
![]() |
A. Kromminga, C. Hagel, R. Arndt, and F. Schuppert Serological Reactivity of Recombinant 1D Autoantigen and Its Expression in Human Thyroid and Eye Muscle Tissue: A Possible Autoantigenic Link in Graves' Patients J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2817 - 2823. [Abstract] [Full Text] |
||||
![]() |
T. Kikumori, F. Kambe, T. Nagaya, T. Imai, H. Funahashi, and H. Seo Activation of Transcriptionally Active Nuclear Factor-{kappa}B by Tumor Necrosis Factor-{alpha} and Its Inhibition by Antioxidants in Rat Thyroid FRTL-5 Cells Endocrinology, April 1, 1998; 139(4): 1715 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ajjan, P. F. Watson, and A. P. Weetman Detection of IL-12, IL-13, and IL-15 Messenger Ribonucleic Acid in the Thyroid of Patients with Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 666 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lakatos, J. Foldes, C. Horvath, L. Kiss, A. Tatrai, I. Takacs, G. Tarjan, and P. H. Stern Serum Interleukin-6 and Bone Metabolism in Patients with Thyroid Function Disorders J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 78 - 81. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |